Lim, R., Schoder, H., Eaton, A., Gonen, M., Rao, S., Sherman, E., . . . Lee, N. (2011). Primary Tumor Metabolic Volume Improves Risk Prediction of Long-term Outcomes in Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy. International Journal of Radiation Oncology, Biology, Physics, 81(2), S17. https://doi.org/10.1016/j.ijrobp.2011.06.035
Chicago Style (17th ed.) CitationLim, R.C, H. Schoder, A. Eaton, M. Gonen, S. Rao, E. Sherman, R. Wong, J. Setton, and N. Lee. "Primary Tumor Metabolic Volume Improves Risk Prediction of Long-term Outcomes in Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy." International Journal of Radiation Oncology, Biology, Physics 81, no. 2 (2011): S17. https://doi.org/10.1016/j.ijrobp.2011.06.035.
MLA (9th ed.) CitationLim, R.C, et al. "Primary Tumor Metabolic Volume Improves Risk Prediction of Long-term Outcomes in Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy." International Journal of Radiation Oncology, Biology, Physics, vol. 81, no. 2, 2011, p. S17, https://doi.org/10.1016/j.ijrobp.2011.06.035.